CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Alexander Zehnder, M.B.A.,M.D.$819.8M
Market Cap • 25/07/20242020
(há 4 anos)
2020
(4 years ago)
NASDAQ
Listagem
Tubingen
Sede • BW1.049
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CVACSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.